ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)

ChoA Pharmaceutical Co., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	31,383	61,371	72,957	116,484	154,280	107,013
Market Cap Growth	-31.78%	-15.88%	-37.37%	-24.50%	44.17%	-13.40%
Enterprise Value	47,355	72,291	79,771	118,025	152,660	108,439
Last Close Price	1013.00	1981.00	2355.00	3760.00	4980.00	3780.00
PE Ratio	-	-	130.12	-	-	-
PS Ratio	0.51	0.97	1.06	2.02	2.36	1.58
PB Ratio	0.89	1.58	1.42	2.41	2.72	2.07
P/TBV Ratio	1.27	1.53	1.40	2.37	2.68	2.04
P/FCF Ratio	-	-	-	-	-	38.67
P/OCF Ratio	-	-	-	-	80.28	25.74
EV/Sales Ratio	0.77	1.15	1.16	2.05	2.34	1.61
EV/EBITDA Ratio	-	-	41.85	-	127.84	45.14
EV/FCF Ratio	-8.62	-	-	-	-	39.18
Debt / Equity Ratio	0.76	0.45	0.36	0.34	0.18	0.35
Debt / EBITDA Ratio	-	-	9.80	-	8.58	7.53
Debt / FCF Ratio	-	-	-	-	-	6.53
Asset Turnover	0.81	0.79	0.83	0.71	0.77	0.79
Inventory Turnover	3.37	3.28	4.03	3.26	3.59	4.12
Quick Ratio	0.82	0.93	1.24	1.38	1.70	1.75
Current Ratio	1.29	1.44	1.76	1.92	2.47	2.30
Return on Equity (ROE)	-33.84%	-24.69%	1.03%	-15.30%	-2.96%	-2.14%
Return on Assets (ROA)	-9.28%	-6.87%	-0.36%	-5.37%	-1.37%	-0.30%
Return on Capital (ROIC)	-11.48%	-8.70%	-0.45%	-6.64%	-1.70%	-0.37%
Earnings Yield	-41.66%	-17.13%	0.77%	-6.91%	-0.85%	-0.85%
FCF Yield	-17.50%	-3.76%	-5.79%	-4.31%	-1.09%	2.59%
Buyback Yield / Dilution	0.44%	-	-	-	-9.43%	-
Total Shareholder Return	0.44%	-	-	-	-9.43%	-

Source: S&P Capital IQ. Standard template. Financial Sources.